93 related articles for article (PubMed ID: 8043453)
1. Raised urinary calmodulin levels in idiopathic myelofibrosis: possible implications for the aetiology of fibrosis.
Eastham JM; Reilly JT; Mac Neil S
Br J Haematol; 1994 Mar; 86(3):668-70. PubMed ID: 8043453
[TBL] [Abstract][Full Text] [Related]
2. Platelet factor-4 excretion in myeloproliferative disease: implications for the aetiology of myelofibrosis.
Burstein SA; Malpass TW; Yee E; Kadin M; Brigden M; Adamson JW; Harker LA
Br J Haematol; 1984 Jul; 57(3):383-92. PubMed ID: 6743563
[TBL] [Abstract][Full Text] [Related]
3. Increased intraplatelet levels of platelet-derived growth factor and transforming growth factor-beta in patients with myelofibrosis with myeloid metaplasia.
Martyré MC; Magdelenat H; Bryckaert MC; Laine-Bidron C; Calvo F
Br J Haematol; 1991 Jan; 77(1):80-6. PubMed ID: 1998600
[TBL] [Abstract][Full Text] [Related]
4. Investigation of calmodulin and basic fibroblast growth factor (bFGF) in idiopathic myelofibrosis: evidence for a role of extracellular calmodulin in fibroblast proliferation.
Dalley A; Smith JM; Reilly JT; Neil SM
Br J Haematol; 1996 Jun; 93(4):856-62. PubMed ID: 8703817
[TBL] [Abstract][Full Text] [Related]
5. Interferon-gamma in vivo reverses the increased platelet levels of platelet-derived growth factor and transforming growth factor-beta in patients with myelofibrosis with myeloid metaplasia.
Martyré MC; Magdelenat H; Calvo F
Br J Haematol; 1991 Mar; 77(3):431-5. PubMed ID: 1901495
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels of basic fibroblast growth factor in megakaryocytes and platelets from patients with idiopathic myelofibrosis.
Martyré MC; Le Bousse-Kerdiles MC; Romquin N; Chevillard S; Praloran V; Demory JL; Dupriez B
Br J Haematol; 1997 May; 97(2):441-8. PubMed ID: 9163611
[TBL] [Abstract][Full Text] [Related]
7. [Role of growth factors of platelets (PDGF, TGF-beta, EGF) in the pathogenesis of myelofibrosis].
Kimura A; Katoh O; Kuramoto A
Rinsho Byori; 1989 Apr; Spec No 81():1-8. PubMed ID: 2787864
[No Abstract] [Full Text] [Related]
8. Megakaryocytes and myelofibrosis in gray platelet syndrome.
Caen JP; Deschamps JF; Bodevin E; Bryckaert MC; Dupuy E; Wasteson A
Nouv Rev Fr Hematol (1978); 1987; 29(2):109-14. PubMed ID: 3615193
[TBL] [Abstract][Full Text] [Related]
9. Reduced platelet PDGF levels in idiopathic myelofibrosis.
Dolan G; Forrest PL; Eastham JM; Reilly JT
Br J Haematol; 1991 Aug; 78(4):586-8. PubMed ID: 1911359
[No Abstract] [Full Text] [Related]
10. [Gray platelet syndrome, an example of myelofibrosis of megakaryocytic origin].
Caen JP; Cramer EM; Rendu F; Bryckaert M; Dupuy E; Levy-Toledano S
Bull Acad Natl Med; 1991 Oct; 175(7):1145-52; discussion 1152-3. PubMed ID: 1809489
[TBL] [Abstract][Full Text] [Related]
11. Reduced responsiveness of bone marrow megakaryocyte progenitors to platelet-derived transforming growth factor beta 1, produced in normal amount, in patients with essential thrombocythaemia.
Zauli G; Visani G; Catani L; Vianelli N; Gugliotta L; Capitani S
Br J Haematol; 1993 Jan; 83(1):14-20. PubMed ID: 8435322
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of growth factor production in the mechanism of fibrosis in agnogenic myeloid metaplasia.
Wang JC; Chang TH; Goldberg A; Novetsky AD; Lichter S; Lipton J
Exp Hematol; 2006 Dec; 34(12):1617-23. PubMed ID: 17157157
[TBL] [Abstract][Full Text] [Related]
13. Platelet-derived mitogenic activity and bone marrow fibrosis in myeloproliferative disorders.
Romano M; Viero P; Cortellazzo S; Barbui T; Donati MB; Poggi A
Haemostasis; 1990; 20(3):162-8. PubMed ID: 2143744
[TBL] [Abstract][Full Text] [Related]
14. The production of tissue inhibitors of metalloproteinases (TIMPs) in megakaryopoiesis: possible role of platelet- and megakaryocyte-derived TIMPs in bone marrow fibrosis.
Murate T; Yamashita K; Isogai C; Suzuki H; Ichihara M; Hatano S; Nakahara Y; Kinoshita T; Nagasaka T; Yoshida S; Komatsu N; Miura Y; Hotta T; Fujimoto N; Saito H; Hayakawa T
Br J Haematol; 1997 Oct; 99(1):181-9. PubMed ID: 9359522
[TBL] [Abstract][Full Text] [Related]
15. Platelet abnormalities in idiopathic myelofibrosis: functional, biochemical and immunomorphological correlations.
Leoni P; Rupoli S; Lai G; Brunelli MA; Belmonte MM; Pugnaloni A; Rabini RA; Mazzanti L; Biagini G
Haematologica; 1994; 79(1):29-39. PubMed ID: 15378946
[TBL] [Abstract][Full Text] [Related]
16. Aberrant expression of platelet-derived growth factor (PDGF) and PDGF receptor-alpha is associated with advanced bone marrow fibrosis in idiopathic myelofibrosis.
Bock O; Loch G; Büsche G; von Wasielewski R; Schlué J; Kreipe H
Haematologica; 2005 Jan; 90(1):133-4. PubMed ID: 15642683
[TBL] [Abstract][Full Text] [Related]
17. Platelet-derived growth factor expression in accelerated and blastic phase of chronic myelogenous leukaemia with myelofibrosis.
Kimura A; Nakata Y; Hyodo H; Kuramoto A; Satow Y
Br J Haematol; 1994 Feb; 86(2):303-7. PubMed ID: 8199019
[TBL] [Abstract][Full Text] [Related]
18. Activation of peroxisome proliferator-activated receptor α in megakaryocytes reduces platelet-derived growth factor-BB in platelets.
Hashizume S; Akaike M; Azuma H; Ishikawa K; Yoshida S; Sumitomo-Ueda Y; Yagi S; Ikeda Y; Iwase T; Aihara K; Abe M; Sata M; Matsumoto T
J Atheroscler Thromb; 2011; 18(2):138-47. PubMed ID: 21060209
[TBL] [Abstract][Full Text] [Related]
19. Idiopathic myelofibrosis serum induces increased DNA synthesis in BALB/c 3T3 cells.
Polato G; Pietrogrande F; Caenazzo A; Piva E; Burlina A; Girolami A
Folia Haematol Int Mag Klin Morphol Blutforsch; 1990; 117(3):469-73. PubMed ID: 1703119
[TBL] [Abstract][Full Text] [Related]
20. Bilateral interstitial pneumonic shadows caused by perivascular fibrosis and extramedullary megakaryopoiesis of the lung in a case of advanced agnogenic myeloid metaplasia and myelofibrosis.
Ueno H; Yoneda R; Ogawa W; Yoon S; Kitazawa S; Kitazawa R; Kasuga M
Acta Haematol; 2000; 104(4):212-6. PubMed ID: 11279314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
